Portis et al., 2001 - Google Patents
Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse modelPortis et al., 2001
View PDF- Document ID
- 982253634501130462
- Author
- Portis T
- Grossman W
- Harding J
- Hess J
- Ratner L
- Publication year
- Publication venue
- Journal of virology
External Links
Snippet
MATERIALS AND METHODS Mice. Granzyme B-Tax transgenic mice (Tax) were generated as previously described (14). Mice containing a homozygous deletion in p53 (p53/) were purchased from Jackson Laboratories (18). Tax mice were mated with p53/mice, and the …
- 230000002779 inactivation 0 title description 23
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Hybridisation probes
- C12Q1/6883—Hybridisation probes for diseases caused by alterations of genetic material
- C12Q1/6886—Hybridisation probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Hecht et al. | Molecular biology of Burkitt’s lymphoma | |
| Gong et al. | Cytokine-dependent Blimp-1 expression in activated T cells inhibits IL-2 production | |
| Lee et al. | Apoptosis, cancer and the p53 tumour suppressor gene | |
| Dimri et al. | Regulation of a senescence checkpoint response by the E2F1 transcription factor and p14ARF tumor suppressor | |
| Malumbres et al. | Cellular response to oncogenic ras involves induction of the Cdk4 and Cdk6 inhibitor p15INK4b | |
| Wagner et al. | The Wilms' tumor gene Wt1 is required for normal development of the retina | |
| Biliran Jr et al. | Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene–expressing pancreatic tumor cell line | |
| Sakamuro et al. | The polyproline region of p53 is required to activate apoptosis but not growth arrest | |
| Zong et al. | BH3-only proteins that bind pro-survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak | |
| Damalas et al. | Deregulated β‐catenin induces a p53‐and ARF‐dependent growth arrest and cooperates with Ras in transformation | |
| Ohshima et al. | Mutation analysis of mitotic checkpoint genes (hBUB1 and hBUBR1) and microsatellite instability in adult T-cell leukemia/lymphoma | |
| Fair et al. | Protein interactions of the MLL PHD fingers modulate MLL target gene regulation in human cells | |
| Park et al. | Cytokine‐induced megakaryocytic differentiation is regulated by genome‐wide loss of a uSTAT transcriptional program | |
| Ruckes et al. | Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309 | |
| Lania et al. | Transcriptional regulation by the Sp family proteins | |
| Wang et al. | Persistent transactivation by meis1 replaces hox function in myeloid leukemogenesis models: evidence for co-occupancy of meis1-pbx and hox-pbx complexes on promoters of leukemia-associated genes | |
| Doan et al. | Targeted transcriptional repression of Gfi1 by GFI1 and GFI1B in lymphoid cells | |
| Niu et al. | BCL6 controls the expression of the B7-1/CD80 costimulatory receptor in germinal center B cells | |
| Malkin | Germline p53 mutations and heritable cancer | |
| Thorsteinsdottir et al. | The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells | |
| Mrowka et al. | Wilms' tumor suppressor gene WT1: from structure to renal pathophysiologic features | |
| Schmidt et al. | Regulation of the resident chromosomal copy of c-myc by c-Myb is involved in myeloid leukemogenesis | |
| Kwon et al. | Crif1 is a novel transcriptional coactivator of STAT3 | |
| Wong et al. | Feed-forward regulatory loop driven by IRF4 and NF-κB in adult T-cell leukemia/lymphoma | |
| Portis et al. | Analysis of p53 inactivation in a human T-cell leukemia virus type 1 Tax transgenic mouse model |